| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.91e-06 | 28 | 150 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.47e-06 | 120 | 150 | 8 | GO:0004222 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 6.06e-06 | 35 | 150 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | endopeptidase activity | USP34 RHBDF1 ADAMTS1 ADAMTS10 MMP24 USP5 ADAMTS9 ADAMTS15 PAPPA ADAM33 MMP8 USP15 ATG4D | 2.26e-05 | 430 | 150 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | retinoid binding | 2.95e-05 | 48 | 150 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.27e-05 | 49 | 150 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | adipokinetic hormone binding | 5.61e-05 | 2 | 150 | 2 | GO:0097004 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.38e-04 | 200 | 150 | 8 | GO:0008237 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.38e-04 | 66 | 150 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.98e-04 | 211 | 150 | 8 | GO:0016758 | |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 3.33e-04 | 4 | 150 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 4.31e-04 | 20 | 150 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | steroid binding | 5.09e-04 | 133 | 150 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | TCF3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 BCL11A SIM1 UGT1A1 MLXIPL PAFAH1B3 | 8.72e-04 | 398 | 150 | 10 | GO:0046982 |
| GeneOntologyMolecularFunction | protein kinase binding | TCF3 WARS1 UGT1A10 UGT1A8 UGT1A7 ROR2 UGT1A9 NBEA SRCIN1 BCL11A EEF1A1 EEF1A2 MLXIPL SHC2 SMO PKN1 | 8.92e-04 | 873 | 150 | 16 | GO:0019901 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.06e-03 | 153 | 150 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.29e-03 | 107 | 150 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | peptidase activity | USP34 RHBDF1 ADAMTS1 ADAMTS10 MMP24 USP5 ADAMTS9 ADAMTS15 PAPPA ADAM33 MMP8 USP15 ATG4D | 1.34e-03 | 654 | 150 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.53e-03 | 288 | 150 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | fatty acid binding | 1.81e-03 | 69 | 150 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | virion binding | 2.42e-03 | 10 | 150 | 2 | GO:0046790 | |
| GeneOntologyMolecularFunction | kinase binding | TCF3 WARS1 UGT1A10 UGT1A8 UGT1A7 ROR2 UGT1A9 NBEA SRCIN1 BCL11A EEF1A1 EEF1A2 MLXIPL SHC2 SMO PKN1 | 2.59e-03 | 969 | 150 | 16 | GO:0019900 |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.02e-10 | 6 | 147 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.23e-08 | 5 | 147 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.23e-08 | 5 | 147 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.11e-08 | 13 | 147 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.67e-08 | 6 | 147 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.67e-08 | 6 | 147 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.19e-07 | 21 | 147 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 5.03e-07 | 10 | 147 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 5.03e-07 | 10 | 147 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.00e-06 | 26 | 147 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.00e-06 | 26 | 147 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.17e-06 | 12 | 147 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.35e-05 | 21 | 147 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.41e-05 | 52 | 147 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | negative regulation of dendrite development | 7.44e-05 | 12 | 147 | 3 | GO:2000171 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 9.72e-05 | 34 | 147 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.85e-04 | 40 | 147 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 2.73e-04 | 176 | 147 | 7 | GO:0007224 | |
| GeneOntologyCellularComponent | preribosome, small subunit precursor | 1.55e-04 | 15 | 150 | 3 | GO:0030688 | |
| GeneOntologyCellularComponent | preribosome | 1.74e-04 | 114 | 150 | 6 | GO:0030684 | |
| GeneOntologyCellularComponent | eukaryotic translation elongation factor 1 complex | 3.04e-04 | 4 | 150 | 2 | GO:0005853 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS1 ANXA3 LAMA3 MATN4 SSPOP ADAMTS10 HMCN1 ADAMTS9 PTPRZ1 VCAN ADAMTS15 MMP8 | 4.53e-04 | 530 | 150 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | Pwp2p-containing subcomplex of 90S preribosome | 7.53e-04 | 6 | 150 | 2 | GO:0034388 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS1 ANXA3 LAMA3 MATN4 SSPOP ADAMTS10 MMP24 HMCN1 ADAMTS9 PTPRZ1 VCAN ADAMTS15 MMP8 | 9.12e-04 | 656 | 150 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS1 ANXA3 LAMA3 MATN4 SSPOP ADAMTS10 MMP24 HMCN1 ADAMTS9 PTPRZ1 VCAN ADAMTS15 MMP8 | 9.37e-04 | 658 | 150 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | ruffle membrane | 1.10e-03 | 108 | 150 | 5 | GO:0032587 | |
| Domain | - | 2.41e-07 | 81 | 147 | 8 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.41e-07 | 81 | 147 | 8 | IPR024079 | |
| Domain | UDPGT | 5.19e-07 | 21 | 147 | 5 | PF00201 | |
| Domain | UDPGT | 5.19e-07 | 21 | 147 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 5.19e-07 | 21 | 147 | 5 | IPR002213 | |
| Domain | ZINC_PROTEASE | 1.05e-06 | 98 | 147 | 8 | PS00142 | |
| Domain | TPR_10 | 9.39e-06 | 6 | 147 | 3 | PF13374 | |
| Domain | TSP_1 | 1.01e-05 | 63 | 147 | 6 | PF00090 | |
| Domain | TSP1 | 1.21e-05 | 65 | 147 | 6 | SM00209 | |
| Domain | TSP1_rpt | 1.21e-05 | 65 | 147 | 6 | IPR000884 | |
| Domain | TSP1 | 1.21e-05 | 65 | 147 | 6 | PS50092 | |
| Domain | Pep_M12B_propep | 1.31e-05 | 39 | 147 | 5 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.31e-05 | 39 | 147 | 5 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 1.49e-05 | 40 | 147 | 5 | PS00427 | |
| Domain | Reprolysin | 1.49e-05 | 40 | 147 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 1.49e-05 | 40 | 147 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.49e-05 | 40 | 147 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 1.49e-05 | 40 | 147 | 5 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.68e-05 | 41 | 147 | 5 | PS00546 | |
| Domain | Disintegrin_dom | 1.68e-05 | 41 | 147 | 5 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 2.13e-05 | 43 | 147 | 5 | IPR001818 | |
| Domain | ADAM_spacer1 | 2.90e-05 | 23 | 147 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.90e-05 | 23 | 147 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.46e-05 | 24 | 147 | 4 | IPR013273 | |
| Domain | Factor_5/8 | 6.15e-05 | 2 | 147 | 2 | IPR024715 | |
| Domain | Transl_elong_EF1A_euk/arc | 6.15e-05 | 2 | 147 | 2 | IPR004539 | |
| Domain | ASX_HYDROXYL | 1.39e-04 | 100 | 147 | 6 | PS00010 | |
| Domain | KINESIN_LIGHT | 1.84e-04 | 3 | 147 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 1.84e-04 | 3 | 147 | 2 | IPR015792 | |
| Domain | EGF_1 | 1.92e-04 | 255 | 147 | 9 | PS00022 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.92e-04 | 106 | 147 | 6 | IPR000152 | |
| Domain | EGF_2 | 2.55e-04 | 265 | 147 | 9 | PS01186 | |
| Domain | Fumarylacetoacetase_C-rel | 3.65e-04 | 4 | 147 | 2 | IPR011234 | |
| Domain | FAA_hydrolase | 3.65e-04 | 4 | 147 | 2 | PF01557 | |
| Domain | - | 3.65e-04 | 4 | 147 | 2 | 3.90.850.10 | |
| Domain | Kinesin_light | 3.65e-04 | 4 | 147 | 2 | IPR002151 | |
| Domain | EGF_CA | 4.10e-04 | 122 | 147 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.47e-04 | 124 | 147 | 6 | IPR001881 | |
| Domain | EGF | 5.55e-04 | 235 | 147 | 8 | SM00181 | |
| Domain | EGF_3 | 5.55e-04 | 235 | 147 | 8 | PS50026 | |
| Domain | FA58C | 5.73e-04 | 21 | 147 | 3 | SM00231 | |
| Domain | FA58C_3 | 5.73e-04 | 21 | 147 | 3 | PS50022 | |
| Domain | FA58C_1 | 5.73e-04 | 21 | 147 | 3 | PS01285 | |
| Domain | FA58C_2 | 5.73e-04 | 21 | 147 | 3 | PS01286 | |
| Domain | Cu-oxidase_3 | 6.06e-04 | 5 | 147 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 6.06e-04 | 5 | 147 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 6.06e-04 | 5 | 147 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 6.06e-04 | 5 | 147 | 2 | PF07732 | |
| Domain | Pentatricopeptide_repeat | 7.54e-04 | 23 | 147 | 3 | IPR002885 | |
| Domain | EGF-like_dom | 8.09e-04 | 249 | 147 | 8 | IPR000742 | |
| Domain | F5_F8_type_C | 8.56e-04 | 24 | 147 | 3 | PF00754 | |
| Domain | FA58C | 8.56e-04 | 24 | 147 | 3 | IPR000421 | |
| Domain | Cu_oxidase_Cu_BS | 9.04e-04 | 6 | 147 | 2 | IPR002355 | |
| Domain | Rab5-bind | 9.04e-04 | 6 | 147 | 2 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 9.04e-04 | 6 | 147 | 2 | IPR015390 | |
| Domain | - | 9.26e-04 | 95 | 147 | 5 | 2.60.120.200 | |
| Domain | Bromodomain_CS | 1.09e-03 | 26 | 147 | 3 | IPR018359 | |
| Domain | EGF-like_CS | 1.10e-03 | 261 | 147 | 8 | IPR013032 | |
| Domain | ADAM_Cys-rich | 1.22e-03 | 27 | 147 | 3 | IPR006586 | |
| Domain | ACR | 1.22e-03 | 27 | 147 | 3 | SM00608 | |
| Domain | EGF_LAM_2 | 1.66e-03 | 30 | 147 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.66e-03 | 30 | 147 | 3 | PS01248 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.67e-03 | 8 | 147 | 2 | IPR004160 | |
| Domain | GTP_EFTU_D3 | 1.67e-03 | 8 | 147 | 2 | PF03143 | |
| Domain | WD40_repeat_CS | 1.91e-03 | 164 | 147 | 6 | IPR019775 | |
| Domain | G_TR_CS | 2.14e-03 | 9 | 147 | 2 | IPR031157 | |
| Domain | EGF_Lam | 2.60e-03 | 35 | 147 | 3 | SM00180 | |
| Domain | Laminin_EGF | 2.60e-03 | 35 | 147 | 3 | PF00053 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.66e-03 | 10 | 147 | 2 | IPR009001 | |
| Domain | BROMODOMAIN_1 | 3.05e-03 | 37 | 147 | 3 | PS00633 | |
| Domain | Bromodomain | 3.29e-03 | 38 | 147 | 3 | PF00439 | |
| Domain | LAM_G_DOMAIN | 3.29e-03 | 38 | 147 | 3 | PS50025 | |
| Domain | Laminin_EGF | 3.29e-03 | 38 | 147 | 3 | IPR002049 | |
| Domain | Laminin_G_2 | 3.81e-03 | 40 | 147 | 3 | PF02210 | |
| Domain | Ig_I-set | 3.96e-03 | 190 | 147 | 6 | IPR013098 | |
| Domain | I-set | 3.96e-03 | 190 | 147 | 6 | PF07679 | |
| Domain | BROMODOMAIN_2 | 4.09e-03 | 41 | 147 | 3 | PS50014 | |
| Domain | Bromodomain | 4.38e-03 | 42 | 147 | 3 | IPR001487 | |
| Domain | BROMO | 4.38e-03 | 42 | 147 | 3 | SM00297 | |
| Domain | - | 4.38e-03 | 42 | 147 | 3 | 1.20.920.10 | |
| Domain | WD40 | 4.47e-03 | 259 | 147 | 7 | PF00400 | |
| Domain | G_TR_1 | 4.53e-03 | 13 | 147 | 2 | PS00301 | |
| Domain | EGF_CA | 4.75e-03 | 86 | 147 | 4 | PF07645 | |
| Domain | LamG | 5.00e-03 | 44 | 147 | 3 | SM00282 | |
| Domain | - | 5.26e-03 | 14 | 147 | 2 | 2.60.40.420 | |
| Domain | WD40 | 5.38e-03 | 268 | 147 | 7 | SM00320 | |
| Domain | TPR_1 | 5.58e-03 | 90 | 147 | 4 | IPR001440 | |
| Domain | TPR_1 | 5.58e-03 | 90 | 147 | 4 | PF00515 | |
| Domain | WD40_repeat | 5.82e-03 | 272 | 147 | 7 | IPR001680 | |
| Domain | - | 5.99e-03 | 207 | 147 | 6 | 1.25.40.10 | |
| Domain | IG | 6.18e-03 | 421 | 147 | 9 | SM00409 | |
| Domain | Ig_sub | 6.18e-03 | 421 | 147 | 9 | IPR003599 | |
| Domain | WD_REPEATS_1 | 6.53e-03 | 278 | 147 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 6.66e-03 | 279 | 147 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.66e-03 | 279 | 147 | 7 | PS50294 | |
| Domain | TPR-contain_dom | 6.71e-03 | 150 | 147 | 5 | IPR013026 | |
| Domain | TPR_2 | 7.15e-03 | 50 | 147 | 3 | PF07719 | |
| Domain | TPR_2 | 7.15e-03 | 50 | 147 | 3 | IPR013105 | |
| Domain | EGF_Ca-bd_CS | 7.25e-03 | 97 | 147 | 4 | IPR018097 | |
| Domain | Hemopexin_CS | 7.74e-03 | 17 | 147 | 2 | IPR018486 | |
| Pathway | WP_ESTROGEN_METABOLISM | 8.15e-07 | 22 | 116 | 5 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.30e-06 | 24 | 116 | 5 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.61e-06 | 25 | 116 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.61e-06 | 25 | 116 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.61e-06 | 25 | 116 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.98e-06 | 26 | 116 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.92e-06 | 28 | 116 | 5 | M19580 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.09e-06 | 14 | 116 | 4 | M39328 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.59e-05 | 39 | 116 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.59e-05 | 39 | 116 | 5 | MM15165 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.59e-05 | 39 | 116 | 5 | MM15695 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.97e-05 | 68 | 116 | 6 | M27303 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.05e-05 | 41 | 116 | 5 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.25e-05 | 45 | 116 | 5 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.01e-05 | 51 | 116 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.60e-05 | 52 | 116 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 8.67e-05 | 55 | 116 | 5 | M14933 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.13e-04 | 12 | 116 | 3 | M39611 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.77e-04 | 143 | 116 | 7 | M27275 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.79e-04 | 64 | 116 | 5 | M9488 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS1 SGSH MUC16 SSPOP UGT1A1 ADAMTS10 ADAMTS9 VCAN ADAMTS15 | 2.20e-04 | 250 | 116 | 9 | M27554 |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.73e-04 | 70 | 116 | 5 | M16794 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.77e-04 | 109 | 116 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.06e-04 | 111 | 116 | 6 | M27416 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.12e-04 | 72 | 116 | 5 | M9257 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.58e-04 | 44 | 116 | 4 | M45014 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.25e-03 | 145 | 116 | 6 | M45512 | |
| Pubmed | 8.34e-12 | 6 | 150 | 5 | 20297805 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 TCF3 DNAJC13 FOXK2 ANK3 TRIO ATXN7L1 ROR2 HIPK2 LAMA3 SRCIN1 HUWE1 SSPOP ESCO1 EEF1A2 DNAAF5 PTPN4 SMPDL3B SHC2 FAM13A VSTM2L LPP ZFHX2 AKAP13 PKN1 VGLL4 CATSPERG USP15 PCNT | 8.48e-12 | 1489 | 150 | 29 | 28611215 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.91e-11 | 7 | 150 | 5 | 8467709 | |
| Pubmed | 2.91e-11 | 7 | 150 | 5 | 8464825 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 20610558 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 18052087 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 17179145 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.51e-10 | 19 | 150 | 6 | 23281178 | |
| Pubmed | 1.73e-10 | 9 | 150 | 5 | 22511988 | ||
| Pubmed | 3.32e-10 | 4 | 150 | 4 | 17558305 | ||
| Pubmed | 3.46e-10 | 10 | 150 | 5 | 23642732 | ||
| Pubmed | 3.46e-10 | 10 | 150 | 5 | 11465080 | ||
| Pubmed | 3.46e-10 | 10 | 150 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.46e-10 | 10 | 150 | 5 | 22558097 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.08e-09 | 12 | 150 | 5 | 20308471 | |
| Pubmed | 1.08e-09 | 12 | 150 | 5 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.08e-09 | 12 | 150 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.75e-09 | 13 | 150 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.75e-09 | 13 | 150 | 5 | 25246029 | |
| Pubmed | 2.71e-09 | 14 | 150 | 5 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.71e-09 | 14 | 150 | 5 | 10836148 | |
| Pubmed | 2.71e-09 | 14 | 150 | 5 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.71e-09 | 14 | 150 | 5 | 14672974 | |
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 32527940 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.87e-09 | 16 | 150 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 8.28e-09 | 17 | 150 | 5 | 20639394 | |
| Pubmed | 1.14e-08 | 18 | 150 | 5 | 20056724 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 15599946 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 27514509 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 5.55e-08 | 24 | 150 | 5 | 24625756 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 AMPD2 CRTC3 GAPVD1 WARS1 SPTBN1 KLC2 HUWE1 EEF1A1 EEF1A2 DNAAF5 USP5 GDA TSR1 NUP37 PAFAH1B3 LPP BYSL ANKRD28 FH USP15 TNS3 KLC1 | 7.48e-08 | 1455 | 150 | 23 | 22863883 |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 16636344 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 17406868 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19996319 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 12847094 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19364970 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 29519853 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 7.86e-08 | 3 | 150 | 3 | 24453052 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 23789755 | ||
| Pubmed | 1.07e-07 | 11 | 150 | 4 | 18695635 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPVD1 BAZ2B PCLO IGDCC3 UGT1A9 NBEA ZBTB41 ACVR1B HUWE1 SSPOP ESCO1 EEF1A1 EEF1A2 ADAMTS9 ADAMTS15 AKAP13 | 1.36e-07 | 736 | 150 | 16 | 29676528 |
| Pubmed | USP34 GAPVD1 WDR36 WARS1 SPTBN1 HUWE1 USP5 UTP18 UBR5 TSR1 BYSL PDCD11 ANKRD28 FH PCNT | 1.70e-07 | 653 | 150 | 15 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMPD2 CRTC3 GAPVD1 CDC42EP4 TRIO SPTBN1 ROR2 KLC2 EEF1A1 EEF1A2 MLXIPL FAM13A MEGF8 LPP AKAP13 TNS3 KLC1 | 2.11e-07 | 861 | 150 | 17 | 36931259 |
| Pubmed | USP34 AMPD2 GAPVD1 FOXK2 RHBDF1 WARS1 ANK3 SPTBN1 NOB1 HIPK2 ZBTB41 HUWE1 GRSF1 VILL TSR1 VCAN LPP PCNT BRWD1 | 2.42e-07 | 1084 | 150 | 19 | 11544199 | |
| Pubmed | USP34 GAPVD1 DNAJC13 WDR36 CDC42EP4 ANK3 MUC16 NBEA ACVR1B HUWE1 GRSF1 VPS52 UTP18 UBR5 ANKRD28 PKN1 | 2.81e-07 | 777 | 150 | 16 | 35844135 | |
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 3.14e-07 | 4 | 150 | 3 | 2108603 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 20628391 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 24220035 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | DNAJC13 UGT1A10 UGT1A8 UGT1A7 UGT1A9 MSL2 UGT1A1 MLXIPL FAM13A | 3.72e-07 | 211 | 150 | 9 | 24097068 |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 4.37e-07 | 15 | 150 | 4 | 38871984 | |
| Pubmed | USP34 NRIP1 WARS1 ANK3 TRIO ADAMTS1 SPTBN1 IFIT5 NBEA RIPK4 DNAAF9 HUWE1 SLC4A3 EEF1A1 EEF1A2 CELSR3 ADAMTS9 TBC1D23 PCNT BRWD1 | 7.36e-07 | 1285 | 150 | 20 | 35914814 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 7.81e-07 | 5 | 150 | 3 | 18597651 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 20565459 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 15057901 | ||
| Pubmed | A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart Development. | 7.81e-07 | 5 | 150 | 3 | 32966817 | |
| Pubmed | 9.17e-07 | 75 | 150 | 6 | 20637190 | ||
| Pubmed | DLGAP2 AMPD2 DNAJC13 ANK3 TRIO SPTBN1 NBEA BCL11A HUWE1 EEF1A1 EEF1A2 GDA UBR5 ANKRD28 PKN1 KLC1 PCNT | 9.89e-07 | 963 | 150 | 17 | 28671696 | |
| Pubmed | 1.53e-06 | 20 | 150 | 4 | 19922873 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 1.56e-06 | 6 | 150 | 3 | 19204906 | |
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 1.56e-06 | 6 | 150 | 3 | 16691565 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 15314648 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 23354118 | ||
| Pubmed | DLGAP2 DNAJC13 WARS1 ANK3 TRIO PCLO SPTBN1 KLC2 NBEA SRCIN1 BCL11A EEF1A1 EEF1A2 MLXIPL USP5 GDA PTPRZ1 VCAN FH KLC1 | 3.77e-06 | 1431 | 150 | 20 | 37142655 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.97e-06 | 281 | 150 | 9 | 28706196 | |
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 23233679 | ||
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 15319294 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 4.33e-06 | 8 | 150 | 3 | 12695355 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 TRIO BCKDK NOB1 KLC2 VPS52 UBR5 TSR1 BRPF1 ANKRD28 TBC1D23 USP15 KLC1 PCNT BRWD1 | 4.67e-06 | 853 | 150 | 15 | 28718761 |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 4.88e-06 | 57 | 150 | 5 | 21886157 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 6.48e-06 | 9 | 150 | 3 | 20732626 | |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 1339448 | ||
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 23095891 | ||
| Pubmed | 1.01e-05 | 66 | 150 | 5 | 19898482 | ||
| Pubmed | 1.17e-05 | 116 | 150 | 6 | 30652415 | ||
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 1.26e-05 | 11 | 150 | 3 | 29337306 | |
| Pubmed | AMPD2 FOXK2 KLC2 HUWE1 USP5 UTP18 FAM13A AKAP13 PKN1 USP15 KLC1 | 1.27e-05 | 503 | 150 | 11 | 16964243 | |
| Pubmed | USP34 NRIP1 GAPVD1 DNAJC13 ATG2B HUWE1 UBR5 ANKRD28 KLC1 PCNT | 1.48e-05 | 418 | 150 | 10 | 34709266 | |
| Pubmed | 1.57e-05 | 35 | 150 | 4 | 22688191 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 1.68e-05 | 12 | 150 | 3 | 19349540 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.68e-05 | 12 | 150 | 3 | 25770910 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26599105 | ||
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 1.85e-05 | 2 | 150 | 2 | 15864130 | |
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 1.85e-05 | 2 | 150 | 2 | 31132973 | |
| Pubmed | The molecular basis of factor V and VIII procofactor activation. | 1.85e-05 | 2 | 150 | 2 | 19765210 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9621515 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8226884 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 10946897 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18981166 | ||
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 1.85e-05 | 2 | 150 | 2 | 7715297 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8706880 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 1.85e-05 | 2 | 150 | 2 | 30782564 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28057741 | ||
| Pubmed | Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. | 1.85e-05 | 2 | 150 | 2 | 15286088 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18454993 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15735794 | ||
| Pubmed | Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism. | 1.85e-05 | 2 | 150 | 2 | 17287628 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11677206 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18430559 | ||
| Pubmed | Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. | 1.85e-05 | 2 | 150 | 2 | 12139570 | |
| Cytoband | 2q37 | 5.52e-08 | 31 | 150 | 5 | 2q37 | |
| Cytoband | 20p13 | 3.63e-04 | 102 | 150 | 4 | 20p13 | |
| GeneFamily | UDP glucuronosyltransferases | 1.07e-06 | 32 | 105 | 5 | 363 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.89e-06 | 19 | 105 | 4 | 50 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.54e-04 | 161 | 105 | 6 | 593 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 4.94e-04 | 6 | 105 | 2 | 1225 | |
| GeneFamily | WD repeat domain containing | 8.43e-04 | 262 | 105 | 7 | 362 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | AMPD2 CDC42EP4 ANK3 FAT3 PCLO SPTBN1 NBEA SRCIN1 BCL11A RNF157 EEF1A2 GDA SHC2 VSTM2L | 8.90e-07 | 488 | 150 | 14 | M39104 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | ANK3 FAT3 MUC16 SRCIN1 BCL11A ACVR1B SLC4A3 EEF1A2 LRRC55 MMP24 CELSR3 TLE2 ZFHX2 PAPPA | 1.36e-06 | 506 | 150 | 14 | M39067 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANK3 PCLO LAMA3 NBEA SRCIN1 BCL11A ACVR1B SSPOP SLC4A3 RNF157 ZFPM2 EEF1A2 MMP24 CELSR3 VCAN ZFHX2 PAPPA CATSPERG KLC1 BRWD1 | 5.37e-06 | 1106 | 150 | 20 | M39071 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP | 1.67e-05 | 194 | 150 | 8 | M4192 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 2.08e-05 | 200 | 150 | 8 | M4590 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | CRTC3 TRIO ADAMTS1 ANXA3 KLC2 SRCIN1 SLC4A3 RNF157 SMPDL3B MEGF8 TSR1 ZFHX2 PAPPA AKAP13 VGLL4 FH ATG4D | 3.46e-05 | 954 | 150 | 17 | MM3689 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 5.55e-05 | 169 | 150 | 7 | M39230 | |
| Coexpression | NABA_MATRISOME | ADAMTS1 ANXA3 LAMA3 MUC16 MATN4 SSPOP ADAMTS10 MMP24 HMCN1 MEGF8 ADAMTS9 TNFSF8 VCAN ADAMTS15 PAPPA ADAM33 MMP8 | 6.82e-05 | 1008 | 150 | 17 | MM17056 |
| Coexpression | NABA_ECM_REGULATORS | 7.14e-05 | 238 | 150 | 8 | M3468 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ANK3 NBEA SRCIN1 BCL11A ACVR1B ZFPM2 MMP24 CELSR3 ZFHX2 PAPPA KLC1 | 7.94e-05 | 465 | 150 | 11 | M39066 |
| Coexpression | NABA_ECM_REGULATORS | 8.02e-05 | 242 | 150 | 8 | MM17062 | |
| Coexpression | NABA_MATRISOME | ADAMTS1 ANXA3 LAMA3 MUC16 MATN4 SSPOP ADAMTS10 MMP24 HMCN1 MEGF8 ADAMTS9 TNFSF8 VCAN ADAMTS15 PAPPA ADAM33 MMP8 | 8.46e-05 | 1026 | 150 | 17 | M5889 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 GAPVD1 DNAJC13 SPTBN1 RNF157 ZNF711 ADAMTS9 LPP DEPDC5 VGLL4 | 4.69e-06 | 225 | 150 | 10 | gudmap_developingGonad_e14.5_ ovary_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | DYNC2H1 FAT3 PCLO HIPK2 IGDCC3 TMTC2 BCL11A SIM1 RUNX3 RFX4 MLXIPL PTPN4 ZFHX2 | 5.26e-05 | 496 | 150 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.98e-05 | 139 | 150 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | MAN1A1 MUC16 GDPD2 SLC4A3 ZFPM2 PTPN4 SMPDL3B HMCN1 ADAMTS9 VCAN TNS3 | 1.01e-04 | 388 | 150 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | NRIP1 GAPVD1 DNAJC13 SPTBN1 RNF157 ZNF711 ADAMTS9 LPP DEPDC5 VGLL4 | 1.03e-04 | 323 | 150 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | MUC16 EEF1A2 MLXIPL TLE2 VSTM2L ADAMTS15 CMKLR1 MSS51 ATG4D ALPK2 | 1.03e-04 | 323 | 150 | 10 | ratio_SC_vs_ECTO_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 1.50e-04 | 161 | 150 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 GAPVD1 DNAJC13 TRIO BAZ2B FAT3 SPTBN1 NBEA BCL11A ESCO1 ZNF711 USP5 ADAMTS9 LPP DEPDC5 VGLL4 | 1.78e-04 | 801 | 150 | 16 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | RHBDF1 FGD2 DYNC2H1 FAT3 PCLO HIPK2 IGDCC3 TMTC2 BCL11A DNAAF9 SIM1 RUNX3 RFX4 MLXIPL PTPN4 SMPDL3B TLE2 ZFHX2 | 2.12e-04 | 986 | 150 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | MAN1A1 ADAMTS1 FAT3 MUC16 BCL11A SLC4A3 ZFPM2 ZNF711 PTPN4 VCAN TNS3 | 2.15e-04 | 423 | 150 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.25e-04 | 172 | 150 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAT3 PCLO IGDCC3 NBEA RFX4 GRSF1 SMYD4 PTPN4 UBR5 PTPRZ1 ANKRD28 PAPPA AKAP13 PCNT | 2.29e-04 | 654 | 150 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.36e-04 | 230 | 150 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.73e-08 | 200 | 150 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-07 | 182 | 150 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.64e-07 | 189 | 150 | 8 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-07 | 190 | 150 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 3.91e-07 | 199 | 150 | 8 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-06 | 172 | 150 | 7 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-06 | 175 | 150 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 3.41e-06 | 187 | 150 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.54e-06 | 188 | 150 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.79e-06 | 190 | 150 | 7 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.83e-06 | 123 | 150 | 6 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-06 | 192 | 150 | 7 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-06 | 192 | 150 | 7 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.06e-06 | 192 | 150 | 7 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.20e-06 | 193 | 150 | 7 | 0dd83b21e164147abfd511a927615c40a28781a2 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 125 | 150 | 6 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.35e-06 | 194 | 150 | 7 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.97e-06 | 198 | 150 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 150 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.14e-06 | 199 | 150 | 7 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 161 | 150 | 6 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.79e-05 | 161 | 150 | 6 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 161 | 150 | 6 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 1.92e-05 | 163 | 150 | 6 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 169 | 150 | 6 | bf0a97f53d6e3f9ffeaeae0402b010c49a6cccb7 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 169 | 150 | 6 | 05b138511039f1255a5f647040b1b9bdf222bd52 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.43e-05 | 170 | 150 | 6 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | 35d09640d5b04fa0bbb1b40d4b8f97da587a5046 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | 98cb64e2a768908105701a7a5b58f336036250fd | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-05 | 172 | 150 | 6 | a53c906539557594ef10368bc29aec4af063fd37 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-05 | 173 | 150 | 6 | 9acad7ec70f713fe3db6cef7bbe3b183bf16ae67 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 174 | 150 | 6 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 174 | 150 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 174 | 150 | 6 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 175 | 150 | 6 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 175 | 150 | 6 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 175 | 150 | 6 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-05 | 175 | 150 | 6 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 177 | 150 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.15e-05 | 178 | 150 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 180 | 150 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 3.45e-05 | 181 | 150 | 6 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.45e-05 | 181 | 150 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 3.56e-05 | 182 | 150 | 6 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-05 | 183 | 150 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 183 | 150 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.67e-05 | 183 | 150 | 6 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 184 | 150 | 6 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-05 | 184 | 150 | 6 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-05 | 185 | 150 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.02e-05 | 186 | 150 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 4.02e-05 | 186 | 150 | 6 | c67f373ba60e8d1ab70dfacc711ee440eaff6fb3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 186 | 150 | 6 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-05 | 188 | 150 | 6 | e2bee29865805d4db30b090d4bce9a1f5311cf51 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 188 | 150 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-05 | 188 | 150 | 6 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.27e-05 | 188 | 150 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.40e-05 | 189 | 150 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.40e-05 | 189 | 150 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 4.53e-05 | 190 | 150 | 6 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.53e-05 | 190 | 150 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.53e-05 | 190 | 150 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.66e-05 | 191 | 150 | 6 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.66e-05 | 191 | 150 | 6 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.66e-05 | 191 | 150 | 6 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 192 | 150 | 6 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.80e-05 | 192 | 150 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 192 | 150 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 4.80e-05 | 192 | 150 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 192 | 150 | 6 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-05 | 192 | 150 | 6 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.94e-05 | 193 | 150 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.94e-05 | 193 | 150 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 4.94e-05 | 193 | 150 | 6 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 194 | 150 | 6 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 5.08e-05 | 194 | 150 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.23e-05 | 195 | 150 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 195 | 150 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.23e-05 | 195 | 150 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.23e-05 | 195 | 150 | 6 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 195 | 150 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.23e-05 | 195 | 150 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 150 | 6 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.38e-05 | 196 | 150 | 6 | 07b557b8530c19ca5b31ad2eac00c36ef1939266 | |
| Drug | naringenin chalcone | 1.16e-11 | 5 | 150 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 1.16e-11 | 5 | 150 | 5 | ctd:C032186 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 6.61e-11 | 12 | 150 | 6 | CID000088735 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.93e-11 | 6 | 150 | 5 | ctd:C543211 | |
| Drug | alloin | 6.93e-11 | 6 | 150 | 5 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 6.93e-11 | 6 | 150 | 5 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 2.41e-10 | 7 | 150 | 5 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 6.40e-10 | 8 | 150 | 5 | ctd:C034890 | |
| Drug | AC1MRQNQ | 1.43e-09 | 9 | 150 | 5 | CID003522271 | |
| Drug | DHPASiU | 1.43e-09 | 9 | 150 | 5 | CID000197602 | |
| Drug | 3-iodophenol | 1.43e-09 | 9 | 150 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 1.43e-09 | 9 | 150 | 5 | CID000186631 | |
| Drug | Chebi:32663 | 1.43e-09 | 9 | 150 | 5 | CID005460873 | |
| Drug | N-benzylformamide | 1.80e-09 | 76 | 150 | 9 | CID000080654 | |
| Drug | 2,6-dihydroxyanthraquinone | 2.85e-09 | 10 | 150 | 5 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 5.19e-09 | 11 | 150 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 5.19e-09 | 11 | 150 | 5 | CID006442661 | |
| Drug | N-OH-DABZ | 8.86e-09 | 12 | 150 | 5 | CID000051366 | |
| Drug | 4-hydroxyestrone | 8.86e-09 | 12 | 150 | 5 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 8.86e-09 | 12 | 150 | 5 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 8.86e-09 | 12 | 150 | 5 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 8.86e-09 | 12 | 150 | 5 | CID000276709 | |
| Drug | Hymecromone | 1.18e-08 | 25 | 150 | 6 | ctd:D006923 | |
| Drug | Woodward's reagent K | 1.24e-08 | 43 | 150 | 7 | CID000077804 | |
| Drug | 2-hydroxyestrone | 1.43e-08 | 13 | 150 | 5 | ctd:C024980 | |
| Drug | tritanol | 1.43e-08 | 13 | 150 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.43e-08 | 13 | 150 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.43e-08 | 13 | 150 | 5 | CID000000411 | |
| Drug | alizarin | 1.43e-08 | 13 | 150 | 5 | ctd:C010078 | |
| Drug | propranolol glucuronide | 2.22e-08 | 14 | 150 | 5 | CID000119515 | |
| Drug | PCB-61 | 2.22e-08 | 14 | 150 | 5 | CID000036401 | |
| Drug | H-Ni | 2.47e-08 | 28 | 150 | 6 | CID000445665 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.10e-08 | 29 | 150 | 6 | CID000125641 | |
| Drug | iberin | 3.10e-08 | 29 | 150 | 6 | CID000010455 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.31e-08 | 15 | 150 | 5 | CID000040469 | |
| Drug | afloqualone | 3.31e-08 | 15 | 150 | 5 | CID000002040 | |
| Drug | naphthyl sulphate | 3.31e-08 | 15 | 150 | 5 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.31e-08 | 15 | 150 | 5 | CID000010752 | |
| Drug | bergamottin | 3.31e-08 | 15 | 150 | 5 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 3.31e-08 | 15 | 150 | 5 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 4.78e-08 | 16 | 150 | 5 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.78e-08 | 16 | 150 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.78e-08 | 16 | 150 | 5 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 6.74e-08 | 17 | 150 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 6.74e-08 | 17 | 150 | 5 | CID000037766 | |
| Drug | BP-3,6-quinol | 7.07e-08 | 33 | 150 | 6 | CID000119292 | |
| Drug | SureCN12722713 | 9.28e-08 | 18 | 150 | 5 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 9.28e-08 | 18 | 150 | 5 | CID000152226 | |
| Drug | Br 2 | 9.28e-08 | 18 | 150 | 5 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 9.28e-08 | 18 | 150 | 5 | CID000036614 | |
| Drug | ApApG | 9.28e-08 | 18 | 150 | 5 | CID003081975 | |
| Drug | C1 11-32 | 9.28e-08 | 18 | 150 | 5 | CID000443077 | |
| Drug | C11131 | 9.28e-08 | 18 | 150 | 5 | CID000443076 | |
| Drug | glabridin | 1.24e-07 | 8 | 150 | 4 | ctd:C107601 | |
| Drug | 9-OH-risperidone | 1.25e-07 | 19 | 150 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.25e-07 | 19 | 150 | 5 | CID000091433 | |
| Drug | almokalant | 1.25e-07 | 19 | 150 | 5 | CID003033962 | |
| Drug | N-Fg | 1.45e-07 | 37 | 150 | 6 | CID000445227 | |
| Drug | tectochrysin | 1.66e-07 | 20 | 150 | 5 | CID005281954 | |
| Drug | AC1L1OBF | 1.66e-07 | 20 | 150 | 5 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.66e-07 | 20 | 150 | 5 | CID000116545 | |
| Drug | entacapone | 1.66e-07 | 20 | 150 | 5 | ctd:C071192 | |
| Drug | 4-methylumbelliferyl glucuronide | 1.72e-07 | 38 | 150 | 6 | CID000091553 | |
| Drug | 1-phenylimidazole | 2.02e-07 | 39 | 150 | 6 | CID000081595 | |
| Drug | estriol-16-glucuronide | 2.17e-07 | 21 | 150 | 5 | CID000122281 | |
| Drug | dulcin | 2.17e-07 | 21 | 150 | 5 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.17e-07 | 21 | 150 | 5 | CID000069186 | |
| Drug | amonafide | 2.79e-07 | 22 | 150 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 2.79e-07 | 22 | 150 | 5 | CID000053167 | |
| Drug | plumbagin | 2.79e-07 | 22 | 150 | 5 | ctd:C014758 | |
| Drug | AC1NFJIQ | 3.19e-07 | 42 | 150 | 6 | CID004659568 | |
| Drug | amidoxime | 3.55e-07 | 23 | 150 | 5 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 3.55e-07 | 23 | 150 | 5 | CID000066651 | |
| Drug | phenanthridine | 3.55e-07 | 23 | 150 | 5 | CID000009189 | |
| Drug | Glucuronides | 3.69e-07 | 10 | 150 | 4 | ctd:D020719 | |
| Drug | anthraflavic acid | 4.25e-07 | 44 | 150 | 6 | CID000006776 | |
| Drug | AS-3201 | 4.46e-07 | 24 | 150 | 5 | CID000153948 | |
| Drug | 5-MOP | 5.55e-07 | 25 | 150 | 5 | CID000002355 | |
| Drug | AzMC | 5.55e-07 | 25 | 150 | 5 | CID000064986 | |
| Drug | N-acetylbenzidine | 5.55e-07 | 25 | 150 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 5.55e-07 | 25 | 150 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 5.55e-07 | 25 | 150 | 5 | CID000013662 | |
| Drug | Thymol | 6.83e-07 | 26 | 150 | 5 | ctd:D013943 | |
| Drug | isoamyl alcohol | 7.22e-07 | 48 | 150 | 6 | CID000031260 | |
| Drug | retigabine | 7.22e-07 | 48 | 150 | 6 | CID000121892 | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | USP34 TCF3 MAN1A1 ATXN7L1 HIPK2 ABCA7 DENND3 SMPDL3B LPP AKAP13 | 7.66e-07 | 197 | 150 | 10 | 4476_DN |
| Drug | Estrone | 7.85e-07 | 112 | 150 | 8 | ctd:D004970 | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.03e-07 | 198 | 150 | 10 | 6013_UP | |
| Drug | licochalcone A | 8.34e-07 | 27 | 150 | 5 | ctd:C070840 | |
| Drug | diflunisal | 8.34e-07 | 27 | 150 | 5 | CID000003059 | |
| Drug | Scopoletin | 8.34e-07 | 27 | 150 | 5 | ctd:D012603 | |
| Drug | DiMeIQx | 8.34e-07 | 27 | 150 | 5 | CID000104739 | |
| Drug | CARMINE | 1.01e-06 | 28 | 150 | 5 | CID000014749 | |
| Drug | erucin | 1.01e-06 | 28 | 150 | 5 | CID000078160 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.01e-06 | 28 | 150 | 5 | CID000081261 | |
| Drug | 1-hydroxypyrene | 1.04e-06 | 51 | 150 | 6 | ctd:C033146 | |
| Drug | sitafloxacin | 1.12e-06 | 4 | 150 | 3 | ctd:C076246 | |
| Drug | hydratropic acid | 1.12e-06 | 4 | 150 | 3 | ctd:C013025 | |
| Drug | prostaglandin B1 | 1.12e-06 | 4 | 150 | 3 | ctd:C034467 | |
| Drug | 2-vanillin | 1.12e-06 | 4 | 150 | 3 | ctd:C060843 | |
| Disease | X-11442 measurement | 3.55e-10 | 9 | 147 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.55e-10 | 9 | 147 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.55e-10 | 9 | 147 | 5 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.55e-10 | 9 | 147 | 5 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 7.08e-10 | 10 | 147 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 7.08e-10 | 10 | 147 | 5 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 1.29e-09 | 11 | 147 | 5 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.29e-09 | 11 | 147 | 5 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.29e-09 | 11 | 147 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.29e-09 | 11 | 147 | 5 | EFO_0010219 | |
| Disease | biliverdin measurement | 2.21e-09 | 12 | 147 | 5 | EFO_0021033 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.94e-09 | 5 | 147 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 2.94e-09 | 5 | 147 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.94e-09 | 5 | 147 | 4 | EFO_0801853 | |
| Disease | xanthurenate measurement | 5.96e-09 | 29 | 147 | 6 | EFO_0010551 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.69e-08 | 17 | 147 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | X-21339 measurement | 2.05e-08 | 7 | 147 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 4.08e-08 | 8 | 147 | 4 | EFO_0800766 | |
| Disease | tissue factor measurement | 5.47e-08 | 21 | 147 | 5 | EFO_0010623 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 7.31e-08 | 9 | 147 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 7.31e-08 | 9 | 147 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 7.31e-08 | 9 | 147 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 7.31e-08 | 9 | 147 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 7.31e-08 | 9 | 147 | 4 | EFO_0802127 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | indole-3-carboxylate measurement | 1.21e-07 | 3 | 147 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.21e-07 | 3 | 147 | 3 | EFO_0022216 | |
| Disease | X-21448 measurement | 1.21e-07 | 10 | 147 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.21e-07 | 10 | 147 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 1.90e-07 | 11 | 147 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.90e-07 | 11 | 147 | 4 | EFO_0600039 | |
| Disease | p-cresol glucuronide measurement | 2.84e-07 | 12 | 147 | 4 | EFO_0800079 | |
| Disease | response to dolutegravir | 3.69e-07 | 30 | 147 | 5 | EFO_0600017 | |
| Disease | pregnenetriol disulfate measurement | 4.08e-07 | 13 | 147 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 4.08e-07 | 13 | 147 | 4 | EFO_0802007 | |
| Disease | X-21441 measurement | 1.34e-06 | 17 | 147 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.71e-06 | 18 | 147 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.40e-06 | 6 | 147 | 3 | EFO_0800566 | |
| Disease | thyroxine measurement | 3.80e-06 | 83 | 147 | 6 | EFO_0005130 | |
| Disease | cholelithiasis | 5.34e-06 | 88 | 147 | 6 | EFO_0004799 | |
| Disease | urate measurement, spine bone mineral density | 1.06e-05 | 58 | 147 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.10e-05 | 28 | 147 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | waist-hip ratio | CMKLR2 FOXK2 MAN1A1 ANK3 DYNC2H1 ATXN7L1 BCL11A SIM1 RFX4 RNF157 ADAMTS10 MLXIPL UTP18 FAM13A MEGF8 ADAMTS9 ANKRD28 TBC1D23 FAM124B | 1.17e-05 | 1226 | 147 | 19 | EFO_0004343 |
| Disease | indoleacetate measurement | 1.42e-05 | 10 | 147 | 3 | EFO_0021015 | |
| Disease | gallstones | 1.74e-05 | 108 | 147 | 6 | EFO_0004210 | |
| Disease | X-24588 measurement | 3.34e-05 | 13 | 147 | 3 | EFO_0800898 | |
| Disease | vitamin D deficiency | 3.44e-05 | 37 | 147 | 4 | EFO_0003762 | |
| Disease | Pontoneocerebellar hypoplasia | 6.47e-05 | 16 | 147 | 3 | cv:C1261175 | |
| Disease | stomach cancer (is_marker_for) | 8.09e-05 | 142 | 147 | 6 | DOID:10534 (is_marker_for) | |
| Disease | vitamin D measurement, COVID-19 | 1.05e-04 | 49 | 147 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | late-onset Alzheimers disease | 1.14e-04 | 292 | 147 | 8 | EFO_1001870 | |
| Disease | apolipoprotein B measurement | AMPD2 CRTC3 DNAJC13 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SIM1 MLXIPL B4GALNT3 ATG4D BRWD1 | 1.28e-04 | 663 | 147 | 12 | EFO_0004615 |
| Disease | ovarian cancer (is_implicated_in) | 1.78e-04 | 56 | 147 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | birth weight | 1.84e-04 | 399 | 147 | 9 | EFO_0004344 | |
| Disease | response to antiviral drug, cirrhosis of liver | 2.27e-04 | 24 | 147 | 3 | EFO_0001422, EFO_0010123 | |
| Disease | scoliosis (implicated_via_orthology) | 2.44e-04 | 5 | 147 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | pontocerebellar hypoplasia (implicated_via_orthology) | 2.44e-04 | 5 | 147 | 2 | DOID:0060264 (implicated_via_orthology) | |
| Disease | gamma-enolase measurement | 3.65e-04 | 6 | 147 | 2 | EFO_0021845 | |
| Disease | eosinophil percentage of leukocytes | NRIP1 CRTC3 WDR36 ATXN7L1 RUNX3 ABCA7 EEF1A1P5 MLXIPL TNFSF8 LPP AKAP13 ALPK2 | 3.74e-04 | 746 | 147 | 12 | EFO_0007991 |
| Disease | obsolete_red blood cell distribution width | NRIP1 DNAJC13 FOXK2 TENT4A BAZ2B BCL11A ABCA7 F8 GRSF1 ZFPM2 EEF1A1 EEF1A1P5 SOX7 MLXIPL FAM222B YDJC AKAP13 | 4.06e-04 | 1347 | 147 | 17 | EFO_0005192 |
| Disease | platelet component distribution width | NRIP1 GAPVD1 TENT4A ZFPM2 MLXIPL LPP ANKRD28 ADAM33 AKAP13 SIGLEC1 USP15 BRWD1 | 4.16e-04 | 755 | 147 | 12 | EFO_0007984 |
| Disease | guanidinoacetate measurement | 5.09e-04 | 7 | 147 | 2 | EFO_0800135 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | age at initiation of corrective lens use | 6.77e-04 | 8 | 147 | 2 | EFO_0021781 | |
| Disease | hormone measurement | 8.38e-04 | 84 | 147 | 4 | EFO_0004730 | |
| Disease | immunoglobulin M measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0020466 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.68e-04 | 147 | 147 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 DNAJC13 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SIM1 UGT1A1 MLXIPL B4GALNT3 BRWD1 | 9.23e-04 | 713 | 147 | 11 | EFO_0005689 |
| Disease | breast cancer (is_implicated_in) | 9.50e-04 | 150 | 147 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | cortical surface area measurement | USP34 DNAJC13 ANK3 BAZ2B FAT3 SPTBN1 HIPK2 DNAAF9 RFX4 DENND3 FAM13A ADAMTS9 VCAN YDJC PAPPA FAM124B | 1.13e-03 | 1345 | 147 | 16 | EFO_0010736 |
| Disease | guanosine diphosphate measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0010494 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 1.32e-03 | 11 | 147 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.38e-03 | 163 | 147 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Inhalant adrenergic use measurement | 1.38e-03 | 96 | 147 | 4 | EFO_0009941 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 1.57e-03 | 12 | 147 | 2 | EFO_0021054 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.85e-03 | 13 | 147 | 2 | C3501611 | |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0020131 | |
| Disease | Abnormality of refraction | NRIP1 DNAJC13 ANK3 FAT3 PCLO NBEA DENND3 FAM13A ADAMTS9 AKAP13 | 2.07e-03 | 673 | 147 | 10 | HP_0000539 |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A10 UGT1A8 UGT1A7 ANXA3 UGT1A9 SOX7 MLXIPL CEPT1 AKAP13 SIGLEC1 ALPK2 KLC1 | 2.14e-03 | 914 | 147 | 12 | EFO_0004532 |
| Disease | venous thromboembolism | 2.22e-03 | 460 | 147 | 8 | EFO_0004286 | |
| Disease | reticulocyte count | USP34 CMKLR2 FOXK2 LAMA3 BCL11A DNAAF9 RUNX3 DENND3 MLXIPL YDJC ADAM33 DEPDC5 TNS3 | 2.25e-03 | 1045 | 147 | 13 | EFO_0007986 |
| Disease | pancreatic cancer (is_implicated_in) | 2.42e-03 | 112 | 147 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Metastatic melanoma | 2.49e-03 | 54 | 147 | 3 | C0278883 | |
| Disease | monocyte count | NRIP1 TCF3 LILRB3 FGD2 BAZ2B SPTBN1 ZFPM2 EEF1A1P5 MLXIPL SMPDL3B VCAN LPP AKAP13 CMKLR1 TNS3 | 2.51e-03 | 1320 | 147 | 15 | EFO_0005091 |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 2.83e-03 | 16 | 147 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 2.83e-03 | 16 | 147 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | neurofilament light chain measurement | 2.91e-03 | 57 | 147 | 3 | EFO_0009178 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 3.01e-03 | 119 | 147 | 4 | EFO_0009268, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKDSAFHIMSHESPG | 991 | Q6ZRH7 | |
| FVMLGPSHTSTDYHE | 556 | P48751 | |
| SQLDHMGFHFTTGIP | 2661 | P13611 | |
| MDEVGHIPQTAASHV | 291 | Q6L9W6 | |
| PIMTHASLGVDTHNS | 1546 | Q86TB3 | |
| AASGLAHLHMEIVGT | 311 | P36896 | |
| SSAFPMVSHPVFGLH | 66 | Q9UIF8 | |
| MVSHPVFGLHSASSG | 71 | Q9UIF8 | |
| QSLHDAGPRETLMHF | 156 | Q12802 | |
| LSGHFEHLMVALVTP | 76 | P12429 | |
| HGMFPLHLAALSGFS | 371 | O15084 | |
| MGFGDISSLAHHLST | 381 | Q9Y2Z9 | |
| DHSELPIGAAATMAH | 331 | Q9BZ11 | |
| PIGAAATMAHEIGHS | 336 | Q9BZ11 | |
| LGDHVSSSTFPRMHY | 151 | Q9P1A6 | |
| AGPIHHLVSAFMLAE | 691 | Q01433 | |
| GHPVHFQEMESLHLS | 1506 | Q9P1Z9 | |
| PTSFLMGCHLDHFEE | 261 | A2RUS2 | |
| SPLFGHLDMHSGAQS | 346 | O14874 | |
| SFSHHFISDAMTGVP | 1471 | Q96BY7 | |
| ALMSHTTAFPHVAAT | 576 | Q9ULK2 | |
| TAFTIAHEIGHTFGM | 386 | Q9H324 | |
| AFTTAHELGHVFNMP | 356 | Q8TE58 | |
| HSVAREPSAAHLSMG | 1856 | Q8IZY2 | |
| HSLGLAHSSDPGALM | 221 | P22894 | |
| SMTDEHGHQRPVAFL | 61 | Q9NRP0 | |
| DMTLHSAPSFGSFHL | 441 | Q33E94 | |
| AFTTAHELGHVFNMP | 396 | Q9UHI8 | |
| VGHLVDHMVHTSPSE | 416 | P29074 | |
| TTSSLHFVHMRGLPF | 396 | Q12849 | |
| PGFVHSDGTISHHDM | 176 | Q15102 | |
| APGRFHVGSAESMLH | 571 | O75140 | |
| HALGLEHSSDPSAIM | 286 | Q9Y5R2 | |
| TTPQAGIHSAMTHGF | 4996 | Q8WXI7 | |
| GIHSAMTHGFSQLDV | 5001 | Q8WXI7 | |
| SHVPADMFQEAHGLV | 126 | Q6ZSA7 | |
| VSVTVSDDGTLHMHF | 296 | Q9ULX3 | |
| EGMASHVQVFSPHTL | 6 | Q9H2X6 | |
| ATMSDFHVHPQATVG | 136 | Q8IVU1 | |
| HMVEHSFSEAQGARP | 471 | O95460 | |
| ETHSFSFHPMAGCEG | 1341 | Q16787 | |
| VAAFHPGFHSSPDLM | 351 | Q4VC12 | |
| AAASPLHMLATHASA | 596 | Q01167 | |
| GVPDASAHSMHTVLD | 366 | Q92485 | |
| DLGHVIDKTSHMPSS | 1381 | Q5HYC2 | |
| DRTPLHMAASEGHAS | 71 | Q06547 | |
| HLNSHSGVKMEEFLP | 316 | Q8WW38 | |
| SPDMDEITHGAHQLT | 801 | Q14C86 | |
| AMFDPLSSHEGASAV | 826 | Q14C86 | |
| RLGAEEMALATHHPS | 281 | Q9H165 | |
| RSMIGEPTNFVHTAH | 26 | Q9NRR3 | |
| IHTADAVTSLPAMHH | 3121 | Q9Y6V0 | |
| PMEHTHAATAALPAA | 326 | Q8WU58 | |
| GHSMVFHAPSRALLV | 391 | Q7Z7M0 | |
| LGHVPARMETTHSFG | 16 | Q93052 | |
| HLSHDAKSAPFLGMA | 771 | P48552 | |
| VSSDGVPFLMHDEHL | 261 | Q9HCC8 | |
| SEMTHFRPQLHHSGD | 851 | P00451 | |
| HHSGDMVFTPESGLQ | 861 | P00451 | |
| TDAMAHVAGFTVAHD | 176 | Q96GK7 | |
| ARFSIPSMTEHHAGR | 81 | O75022 | |
| GVQTAHFVLHSPGMS | 156 | Q8NFH4 | |
| VPVFDVSPTSHMHSA | 1241 | P23471 | |
| DMETHGAHTALPQLL | 271 | Q13219 | |
| EKDGGHTQHFESPTM | 516 | O94988 | |
| LHTFTDTMLPGCFHL | 1436 | Q7Z6Z7 | |
| LSHNVFMSTSPALHG | 311 | Q9HCI7 | |
| FTVSDHPPEQHGMFT | 146 | O95613 | |
| EGTASLKAVHHMSSP | 676 | Q5XG87 | |
| LGLDAHLTVSTHGMV | 3476 | Q96RW7 | |
| TSGHDHPDVATMLNI | 231 | Q9H0B6 | |
| SLVSHMHGAVLFSPK | 2666 | Q8NCM8 | |
| TIAHELGHVFNMPHD | 431 | Q9P2N4 | |
| KSEMHLHDTAFIGPA | 341 | Q9Y6K0 | |
| FQVSSPAMGAHLHLS | 321 | Q9H5Z6 | |
| LGIPHSHSMLDVYET | 216 | Q7L8L6 | |
| LEVTPTSSFLHHQMG | 276 | Q13325 | |
| TDAMAHVAGFTVAHD | 176 | Q6P2I3 | |
| LPASLDTTDHHFGSM | 286 | Q6UUV7 | |
| FPTAMHIAAAIEVHE | 191 | P07954 | |
| SVEMHHEALSEALPG | 291 | Q05639 | |
| SVEMHHEALSEALPG | 291 | P68104 | |
| LGGEHQEMTTFHPES | 4256 | Q8TDW7 | |
| KHAESIMSFHIDLGP | 201 | Q9H3Q1 | |
| PVHFHGSSNFLMIAL | 616 | Q5TEA3 | |
| HPVDISDVFIHTMGT | 281 | Q8IZF7 | |
| ESGLTPIHVAAFMGH | 431 | Q12955 | |
| THPFDSRIMLSAGHD | 476 | Q9NSI6 | |
| SEGALPRHLHTAMFT | 606 | O75165 | |
| EFMHLSHLSGNPIFA | 356 | P33908 | |
| SVEMHHEALSEALPG | 291 | Q5VTE0 | |
| EASGSLTLQHHMLEP | 231 | Q7Z6J4 | |
| HEFFMPGLVDTHIHA | 71 | Q9Y2T3 | |
| PSIQHFPHSAEMLGS | 56 | Q5JT82 | |
| ALEMHHPVTQSTFLG | 426 | Q5FWF5 | |
| ATPDHFHMQSESLIG | 196 | Q86Y56 | |
| QAHAGPTDLDVAMFH | 2871 | Q9NYQ7 | |
| PTLEKAATMTAAGHH | 106 | Q13895 | |
| TSGHDHPDVATMLNI | 246 | Q07866 | |
| IATIGFDSHLHSPMY | 46 | Q15619 | |
| DDSASPRMFHAHSGS | 656 | Q9UPX6 | |
| TAVLHFIHGMTDPVL | 361 | Q8WU17 | |
| SLSVAGMPATSRFHH | 291 | Q13761 | |
| SEAMHVGHLIPFIFT | 166 | P23381 | |
| ISHVHTMDFSPRSGY | 521 | Q9Y5J1 | |
| HPDSATGAMALSGHV | 341 | Q9BT81 | |
| VRHGPSSVEMGHELF | 731 | Q8IYR2 | |
| HFIMGGEKFDSTHPE | 36 | Q96PX1 | |
| ASGVPHHGESVQMVT | 2331 | A2VEC9 | |
| HLLGMSSGPELFSIH | 256 | P12259 | |
| ASIFVHSPHALMLQD | 466 | Q8NFP9 | |
| SMPAETAHISSPHHE | 51 | Q96CC6 | |
| GSHFDVTSHLRMQPD | 736 | P81133 | |
| GDLMLHIHSDVFSEP | 701 | Q16512 | |
| LHEFLVMRSPHSDVG | 561 | Q01974 | |
| EMPHHDLHSVDSLGT | 481 | Q68CZ2 | |
| VIHSGHFMVSSPHSD | 46 | Q9NP71 | |
| SHSHDLSMDGLFGTI | 171 | P57078 | |
| VFGSQSHHEVTMSYP | 361 | P51688 | |
| VGERMPLATSTDHGH | 1501 | Q01082 | |
| IDFETGMHIPHSLAG | 741 | P55201 | |
| LLELHHTAMPGSVFS | 281 | Q99788 | |
| SYSHHVMQAGIPLST | 276 | P46091 | |
| PMFTLAEGHAQDHSL | 426 | Q86TL0 | |
| ERAVAPTMSLHGSHL | 106 | Q14135 | |
| EDGHTALNTHSVSPM | 1126 | Q14690 | |
| VSGPAAHDLFHAVMG | 406 | Q8N1B4 | |
| GDTAMHVPAGSVASH | 16 | P32971 | |
| HSLIATGHLMSVDPD | 676 | Q2NL82 | |
| DLLGHPMTRAFITHA | 356 | Q9HAW8 | |
| PMTRAFITHAGSHGV | 361 | Q9HAW8 | |
| AFMDHTQSHGVKLTP | 251 | Q9C0A1 | |
| SSLDTLHALIAHMFP | 201 | Q9C0H9 | |
| VIANHHMPSISFASG | 241 | P98077 | |
| SHAVGTAGDMHTLLP | 406 | P15923 | |
| SHPEDGLAGSTSLMH | 446 | P15923 | |
| LHQAFEDAMDGLPSH | 416 | Q8N2H3 | |
| LMFASHPIHTEAVAG | 121 | Q8N394 | |
| SSLEMHFRTHSGEKP | 681 | Q5SVQ8 | |
| ESGHMFPSHLLVTAT | 601 | Q9NUY8 | |
| LGHPMTRAFITHAGS | 361 | P22309 | |
| THHTGSSLFGQPFLM | 581 | Q9Y4E8 | |
| GTLAGHTLTAELMAH | 231 | A8MPS7 | |
| FEPTGVGHLETLHMA | 191 | Q9BZZ2 | |
| DLLGHPMTRAFITHA | 356 | O60656 | |
| PMTRAFITHAGSHGV | 361 | O60656 | |
| ELSFSMHTVSHDGPV | 586 | Q99835 | |
| MHTVSHDGPVAGLAF | 591 | Q99835 | |
| HVTMGSEPPHFLAIF | 471 | O15195 | |
| PEHHDGRMTSAEVGA | 6 | Q6ICL7 | |
| PEHDISGEMNATHIA | 701 | Q70CQ2 | |
| MANSSFIGDHVHGAP | 1 | Q6P280 | |
| HVSGHALFTETPHDM | 36 | Q96N03 | |
| GSLGLHTPDSRMAHT | 6 | Q9Y462 | |
| VMAFESHPHLRGSSV | 391 | Q04725 | |
| MVLDPSLAEHLSHFG | 266 | P45974 | |
| DLLGHPMTRAFITHA | 356 | Q9HAW7 | |
| PMTRAFITHAGSHGV | 361 | Q9HAW7 | |
| SYTEIGTSHPHAMEL | 366 | O75962 | |
| IHSAHPSVIIDADAM | 256 | O95071 | |
| DLLGHPMTRAFITHA | 356 | Q9HAW9 | |
| PMTRAFITHAGSHGV | 361 | Q9HAW9 | |
| MSPTGDFLATSHVDH | 671 | Q8NI36 |